Cargando…
Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea
Endocrine therapy is the mainstay treatment for hormone receptor-positive ductal carcinoma in situ. The aim of this study was to examine the long-term secondary malignancy risk of tamoxifen therapy. The data of patients diagnosed with breast cancer between January 2007 and December 2015 were retriev...
Autores principales: | Kim, Dooreh, Oh, Jooyoung, Seok, Jeong-Ho, Lee, Hye Sun, Jeon, Soyoung, Yoon, Chang Ik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954831/ https://www.ncbi.nlm.nih.gov/pubmed/36832280 http://dx.doi.org/10.3390/diagnostics13040792 |
Ejemplares similares
-
Risk of developing depression from endocrine treatment: A nationwide cohort study of women administered treatment for breast cancer in South Korea
por: Oh, Jooyoung, et al.
Publicado: (2022) -
Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016) -
Marked Reduction in the Risk of Dementia in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study
por: Oh, Jooyoung, et al.
Publicado: (2023) -
Prevalence and risk factors for suicide in patients with sepsis: nationwide cohort study in South Korea
por: Oh, Tak Kyu, et al.
Publicado: (2022) -
Dementia Risk among Coronavirus Disease Survivors: A Nationwide Cohort Study in South Korea
por: Park, Hye-Yoon, et al.
Publicado: (2021)